Dicot's study results selected for presentation at European Society for Sexual Medicine
Uppsala, December 8, 2022. The pharmaceutical company Dicot announces that results from the latest study of the mechanism of action of LIB-01 have been selected to be presented at the European Society for Sexual Medicine's annual congress in February 2023.The European Society for Sexual Medicine (ESSM) is the leading scientific society in sexual medicine and the annual congress in February brings together prominent researchers and clinicians from all over the world. Dicot together with the partner Pelvipharm submitted an abstract with results from the latest study of the mechanism of